Comparative Long-Term Outcomes of Tacrolimus, Cyclosporine and Infliximab for Steroid-Refractory Ulcerative Colitis - Week 52 Results Swiss IBD Cohort Study

Please use this identifier to cite or link to this item: https://rfos.fon.bg.ac.rs/handle/123456789/1035

Full metadata record

DC Field	Value	Language
dc.creator	Protić, Marijana
dc.creator	Frei, Pascal
dc.creator	Radojičić, Zoran
dc.creator	Schoepfer, Alain
dc.creator	Juillerat, Pascal
dc.creator	Mottet, Christian
dc.creator	Rogler, Gerhard
dc.creator	Beglinger, Christoph
dc.creator	Seibold, Frank
dc.date.accessioned	2023-05-12T10:35:40Z	-
dc.date.available	2023-05-12T10:35:40Z	-
dc.date.issued	2013
dc.identifier.issn	0016-5085
dc.identifier.uri	https://rfos.fon.bg.ac.rs/handle/123456789/1035	-
dc.publisher	W B Saunders Co-Elsevier Inc, Philadelphia
dc.rights	restrictedAccess
dc.source	Gastroenterology
dc.title	Comparative Long-Term Outcomes of Tacrolimus, Cyclosporine and Infliximab for Steroid-Refractory Ulcerative Colitis - Week 52 Results Swiss IBD Cohort Study	en
dc.type	conferenceObject
dc.rights.license	ARR
dc.citation.epage	S429
dc.citation.issue	5
dc.citation.other	144(5): S428-S429
dc.citation.rank	aM21
dc.citation.spage	S428
dc.citation.volume	144
dc.identifier.rcub	conv_1569
dc.identifier.wos	000322997202349
dc.type.version	publishedVersion
item.cerifentitytype	Publications	-
item.fulltext	No Fulltext	-
item.grantfulltext	none	-
item.openairetype	conferenceObject	-
item.openairecristype	http://purl.org/coar/resource_type/c_18cf	-
Appears in Collections:	Radovi istraživača / Researchers’ publications

Check